⋮
0
0
Teva and Regeneron Announce Global Collaboration to Develop and Commercialize Fasinumab, an Investigational NGF Antibody for Chronic Pain
Showing live article 347 of 1030 in channel 61714629
Article Details:
Author:
Language: English
Channel Number: 61714629
Article Number: 347
Date: September 20, 2016, 4:08 am
URL: http://www.eei-biotechfinances.com/teva-and-regeneron-announce-global-collaboration-to-develop-and-commercialize-fasinumab-an-investigational-ngf-antibody-for-chronic-pain/
GUID: http://www.eei-biotechfinances.com/teva-and-regeneron-announce-global-collaboration-to-develop-and-commercialize-fasinumab-an-investigational-ngf-antibody-for-chronic-pain/
←
$
..going to article 347
X
X
NSFW?
Claim
0
X
Mark channel Not-Safe-For-Work?
cancel
confirm
NSFW Votes:
(
0
votes)
X
Are you the publisher?
Claim
or
contact us about
this channel.
X
No ratings yet.
X
RSSing.com
Search
Sharing:
Title:
URL:
Copy Share URL